Nu-Med Plus (NUMD) Ratios
Nu-Med Plus Ratios
NUMD's free cash flow for Q2 2026 was $1.13K. For the 2026 fiscal year, NUMD's free cash flow was increased by $0.00 and operating cash flow was $1.13K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.03 | 0.04 | 0.08 | 0.56 | 0.08 |
| Quick Ratio | 0.03 | 0.04 | 0.08 | 0.56 | 0.08 |
| Cash Ratio | 0.00 | 0.01 | 0.04 | 0.51 | 0.08 |
| Solvency Ratio | -0.20 | -0.02 | -0.77 | -0.84 | -5.23 |
| Operating Cash Flow Ratio | -0.17 | -0.02 | -0.41 | -0.27 | -1.34 |
| Short-Term Operating Cash Flow Coverage | -0.43 | -0.04 | -0.66 | -0.38 | -25.16 |
| Net Current Asset Value | $ -271.28K | $ -215.10K | $ -146.75K | $ -63.02K | $ -142.85K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 14.22 | 10.67 | 7.43 | 1.26 | 0.37 |
| Debt-to-Equity Ratio | -0.41 | -0.46 | -0.68 | -1.59 | -0.06 |
| Debt-to-Capital Ratio | -0.71 | -0.87 | -2.14 | 2.70 | -0.07 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.03 | -0.04 | -0.09 | -1.26 | -0.17 |
| Debt Service Coverage Ratio | -0.47 | -0.60 | -1.13 | -1.70 | -99.49 |
| Interest Coverage Ratio | 6.77 | -12.63 | -24.11 | -182.17 | 0.00 |
| Debt to Market Cap | 0.08 | 0.08 | 0.03 | 0.08 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -2.28 | -1.54 | -0.79 | -0.16 | 0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 114.76% | 107.92% | 104.15% | 71.45% | 98.93% |
| Return on Assets (ROA) | -710.18% | -729.17% | -932.86% | -163.64% | -3744.98% |
| Return on Equity (ROE) | 20.71% | 31.77% | 85.54% | 206.53% | 627.09% |
| Return on Capital Employed (ROCE) | 18.05% | 29.44% | 82.13% | 289.04% | 633.89% |
| Return on Invested Capital (ROIC) | 30.83% | 55.02% | 257.80% | -509.02% | 723.81% |
| Return on Tangible Assets | -710.18% | -729.17% | -932.86% | -163.64% | -3744.98% |
| Earnings Yield | -3.89% | -5.33% | -3.80% | -9.87% | -32.32% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.24 | 0.31 | 0.43 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -1533.76 | -1169.77 | -851.41 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 1533.76 | 1169.77 | 851.41 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.43 | -0.04 | -0.66 | -0.38 | -25.16 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -3.32% | -0.35% | -2.01% | -2.92% | -8.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -24.69 | -19.19 | -26.33 | -10.13 | -3.09 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -5.32 | -5.96 | -22.53 | -20.93 | -19.40 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -30.09 | -289.30 | -49.79 | -34.28 | -12.42 |
| Price-to-Operating Cash Flow Ratio | -30.09 | -289.30 | -49.79 | -34.28 | -12.42 |
| Price-to-Earnings Growth (PEG) Ratio | 1.97 | 0.41 | 4.21 | 0.12 | 0.04 |
| Enterprise Value Multiple | -31.78 | -21.79 | -28.74 | -7.84 | -3.14 |
| Enterprise Value | 1.56M | 1.38M | 3.40M | 1.35M | 2.56M |
| EV to EBITDA | -31.78 | -21.79 | -28.74 | -7.84 | -3.14 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -32.42 | -311.32 | -51.20 | -34.98 | -12.40 |
| EV to Operating Cash Flow | -32.42 | -311.32 | -51.20 | -34.98 | -12.40 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.15 | 1.08 | 1.04 | 0.71 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.85 | 0.06 | 0.53 | 0.30 | 0.25 |
Currency in USD
